Loading clinical trials...
Loading clinical trials...
Impact of Genetic Polymorphisms of Vasoactive Peptides on the Prognosis of Patients Diagnosed With Mild and Severe Cases of COVID19
Conditions
Interventions
Analysis of genetic polymorphisms of vasoactive peptides in COVID-19
Locations
2
Brazil
Guarulhos City Hall
Guarulhos, São Paulo, Brazil
University Ninth of July
São Paulo, São Paulo, Brazil
Start Date
January 1, 2022
Primary Completion Date
January 1, 2022
Completion Date
February 1, 2022
Last Updated
December 16, 2021
NCT06631287
NCT05141058
NCT06679140
NCT06160128
NCT07300839
NCT05566483
Lead Sponsor
Leonardo Paroche de Matos
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions